论文部分内容阅读
支气管哮喘是一种慢性非特异性炎症和气道高反应性疾病,多有反复发作性喘息、呼吸困难、胸闷、咳嗽等表现,雾化吸入是治疗呼吸系统疾病时常用的一种给药途径,由于局部雾化用药具有奏效快,药物用量小及全身副作用少等优点,是一种理想的给药途径,本科自2001年开始使用氧气驱动雾化吸入器治疗支气管哮喘急性发作患者,取得了良好的疗效,并且避免了超声雾化吸入引起的不良反应,现以普米克令舒(吸入用布地奈德)雾化液雾化吸入为例,报告如下。
Bronchial asthma is a chronic non-specific inflammation and airway hyperresponsiveness disease, and more recurrent wheezing, dyspnea, chest tightness, cough and other performance, inhalation of inhalation is a common route of administration for the treatment of respiratory diseases, due to Local aerosol medication has the advantages of rapid response, small drug dosage and systemic side effects and other advantages, is an ideal route of administration, undergraduate since 2001, the use of oxygen-driven aerosol inhaler in the treatment of acute exacerbation of bronchial asthma, and achieved good Efficacy, and to avoid the adverse effects caused by ultrasonic atomization inhalation, now pulmicort respire (inhalation of budesonide) inhalation of atomized liquid as an example, the report is as follows.